NuScale Faces Analyst Downgrades as Stock Drops 14% in a Week

SMR shares fell 14% over the past week to close at $5.58, a 33% decline over the past month, with the most aggressive sell-side moves of the year arriving this week as the stock hits fresh lows.

The trigger for this week's acceleration is the Street finally repricing the stock toward where it trades. Barclays downgraded to Underweight on October 20 and cut its target from $11 to $5, a halving that reflects deepening scepticism about NuScale's near-term prospects. Citigroup, already at Sell, followed on October 21 with a further cut from $6.50 to $4. Both moves bring their targets close to or below the current price, a rare capitulation signal. Targets across the coverage group have compressed sharply: eight analysts rate the stock Hold, two rate it Underperform, and no current ratings carry an outright Buy from a major firm at target prices that make sense against a $5.58 stock. The consensus mean target of $11.37 is an average dragged upward by staler, higher targets from B. Riley and Canaccord, both of which cut their own numbers substantially in August. The broad direction is unambiguous: the Street has been lowering targets for months and this week the tone shifted from cautious to bearish.

Short interest, at 27.8% of free float, tells a story of persistent institutional conviction on the short side, but the position has been broadly stable this week, down fractionally from around 77.6 million shares. The more notable move over the past month is that short interest climbed roughly 20% in absolute shares, driven by a jump in mid-September when the short count rose from around 65 million to nearly 80 million shares. That accumulation happened while the stock was trading above $8, so shorts built in size at higher prices and now sit comfortably in profit. Borrow availability has loosened noticeably this week, rising to 37.6% from around 24% a week ago, which means capacity exists for new short positions at borrowing costs that remain low, below 0.9% annualised. Options markets reinforce the bullish-on-calls picture: the put/call ratio of 0.37 is at its 52-week low, well below its 20-day average of 0.44, sitting nearly 1.7 standard deviations below that mean. That reads as call-heavy positioning, speculative buyers expecting a bounce rather than hedgers protecting gains.

On the ownership register, Fluor Corporation remains the one 13D activist, though it has cut its stake from 7.8% to 3.9% as last disclosed in April 2026. That halving of a strategic industrial partner's position is a meaningful signal in a company whose bull case rests on industrial execution partnerships. Van Eck and BlackRock have both been active buyers recently, with BlackRock adding 13 million shares in the quarter to September 30 and Van Eck adding 9.3 million. Mirae Asset added 10 million shares, making it the fifth-largest reported holder at 3.2% of shares. These are largely passive and ETF-related flows, not conviction buying from active managers. Fluor's continued retreat is the more pointed message. On the insider side, CFO Robert Ramsey exercised and sold shares under a pre-arranged 10b5-1 plan on October 1, a mechanical transaction that carries limited signalling value. His discretionary August sale of nearly 30,000 shares at $9.39 is the more notable data point, representing a sale into strength that now looks prescient.

Wikipedia attention has dropped to 2.1 standard deviations below its own 90-day history, which reflects diminishing retail interest rather than any revenue indicator. With earnings due November 5, the next data point that matters is not an alt-data series but the question of whether NuScale can show any progress on converting its TVA and ENTRA1 pipeline into contracted, funded commitments, or whether the regulatory and financing timeline continues to stretch.